Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Replacement in Kidney Transplant Recipients
NCT04382157Phase 2Unknown
- Sponsor
- Oslo University Hospital
- Start
- Feb 2020
- Primary completion
- Aug 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of Magnesium hydroxide in hypomagnesemia, sponsored by Oslo University Hospital. Status: unknown.
02
Drugs
Magnesium hydroxide
03
Conditions
hypomagnesemia
Beyond the preview
Go deeper on NCT04382157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04382157.